Related Articles
Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line
Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line
Combination treatment with paclitaxel and doxorubicin inhibits growth of human esophageal squamous cancer cells by inactivation of Akt
XPD inhibits cell growth and invasion and enhances chemosensitivity in esophageal squamous cell carcinoma by regulating the PI3K/AKT signaling pathway
Development and characterization of five cell models for chemoresistance studies of human ovarian carcinoma